Business
QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase
VENLO, the Netherlands, May 07, 2025--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today confirmed strong Q1 2025 results in line with the preliminary announcement and reaffirmed its FY 2025 outlook based on the solid start to the year and evolving macroeconomic trends.
About this update from Qiagen N.v.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":242,"height":204,"url":"https://media.zenfs.com/en/business-wire.com/9e06f1729ec8f63917092e0f08a47c06"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QlBrrO7jv7a8q6HxCxzC6Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM1NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/9e06f1729ec8f63917092e0f08a47c06","width":242,"height":204}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Q1 2025 results confirm preliminary announcement: Net sales of $483 million (+5% actual rates, +7% constant exchange rates, CER); adjusted diluted EPS of $0.55","length":159,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Net sales growth of +7% CER ahead of outlook for about +3% CER growth and adjusted diluted EPS of $0.56 CER ahead of outlook for at least $0.50 CER","length":147,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"29.8% adj. operating income margin up 4.1 percentage points vs. 25.7% in Q1 2024","length":80,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Operating cash flow of $140 million in Q1 2025 vs. $133 million in Q1 2024","length":74,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":301,"olType":false}]},{"val":[{"type":"text","content":"Proposal at Annual General Meeting to introduce a dividend as expansion of capital allocation strategy, also seek authorization for a new $500 million share repurchase","length":167,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Stephen H. Rusckowski proposed to become new Chairman of Supervisory Board as Lawrence A. Rosen chooses to step down from Board after upcoming AGM","length":146,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"2025 outlook reaffirmed for about 4% CER sales growth (about +5% CER core sales growth); recently increased adj. diluted EPS outlook reaffirmed for about $2.35 CER","length":163,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":936,"olType":false},{"type":"text","content":"VENLO, the Netherlands, May 07, 2025--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today confirmed strong Q1 2025 results in line with the preliminary announcement and rea...